Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Randomized Double Blind Phase III Trial of Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy
pazopanib
VEG110727
NCT00753688
Sarcoma, Soft tissue
Phase 3
 
Patients remain on long-term treatment with regular follow up. These follow up data are not included in the datasets provided.
May 2013

Powered by ideaPoint, Inc.